Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crovela Therapeutics
Waltham, Massachusetts, United States
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Crovela Therapeutics is a biotechnology company focused on developing next-generation RNA interference (RNAi) therapies to treat cardiovascular and metabolic diseases. The company leverages a proprietary siRNA platform designed to improve the potency, durability, and delivery of oligonucleotide therapeutics beyond current industry standards. Founded by industry veterans with deep expertise in RNA medicine, Crovela aims to address high-unmet-need indications through highly targeted gene silencing. The company is currently in the pre-clinical stage, advancing a pipeline of candidates toward regulatory filings. Crovela is backed by leading life science investors, including Bain Capital Life Sciences, Atlas Venture, and GV.
- Therapeutic areas
- CardiovascularMetabolic Disorders
- Modalities
- Small interfering RNARNA therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Crovela Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crovela Therapeutics.